Becker MI, Juica F, Jamett A, Tzichinovsky S, Barros S, Aguayo J, De Ioannes AE. Development of anti-human B blood group monoclonal antibodies suitable as a blood typing reagent.
Hybridoma (Larchmt) 1994;
13:303-10. [PMID:
7806251 DOI:
10.1089/hyb.1994.13.303]
[Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
An improved procedure for the generation of high-avidity anti-human B blood group monoclonal antibodies (MAbs) was developed. One of them, termed 7A1-2, showed excellent qualities of titer, avidity, and intensity required for use as human B blood typing reagent. Hemagglutination inhibition studies with monosaccharides and oligosaccharides were carried out to determine the specificity of the MAb 7A1-2. These studies indicate that the antibody reacts with the immunodominant region of the antigen which is known to confer the serologic specificity of this blood group.
Collapse